According to Heidelberg Pharma's latest financial reports the company's current revenue (TTM) is A$15.51 M. In 2023 the company made a revenue of A$15.58 M a decrease over the revenue in the year 2022 that were of A$28.7 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.